Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,142 papers from all fields of science
Search
Sign In
Create Free Account
Tumor Suppressor Proteins
Known as:
Tumor Suppressor Protein
, Proteins, Tumor Suppressor
, Tumor Suppressor Proteins [Chemical/Ingredient]
Expand
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
Narrower (34)
ADAM11 protein, human
BAP1 protein, human
DCC protein, human
DLC-1 (deleted in liver cancer) protein, mouse
Expand
APC protein, human
CDKN1C protein, human
CDKN3 protein, human
Cyclin-Dependent Kinase Inhibitor 2A, human
Expand
Broader (1)
Cell Cycle Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
In vitro and in vivo anti-melanoma action of metformin.
K. Janjetovic
,
Ljubica Harhaji-Trajković
,
+6 authors
V. Trajković
European Journal of Pharmacology
2011
Corpus ID: 30048433
Review
2004
Review
2004
Cell-cycle targeted therapies.
C. Swanton
The Lancet Oncology
2004
Corpus ID: 475255
Highly Cited
2003
Highly Cited
2003
The insulator binding protein CTCF associates with the nuclear matrix.
Katherine L. Dunn
,
Helen Zhao
,
J. Davie
Experimental Cell Research
2003
Corpus ID: 31497529
Review
2001
Review
2001
Why Is p53 Acetylated?
C. Prives
,
J. Manley
Cell
2001
Corpus ID: 18136579
Highly Cited
2001
Highly Cited
2001
The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C*
H. Okuda
,
Kojiro Saitoh
,
+6 authors
T. Shuin
Journal of Biological Chemistry
2001
Corpus ID: 25126530
The von Hippel-Lindau tumor-suppressor protein (pVHL) forms a protein complex (VCB-Cul2) with elongin C, elongin B, Cul-2, and…
Expand
Highly Cited
2001
Highly Cited
2001
The PTEN Tumor Suppressor Protein Inhibits Tumor Necrosis Factor-induced Nuclear Factor κB Activity*
Jason A. Gustin
,
T. Maehama
,
J. Dixon
,
D. Donner
Journal of Biological Chemistry
2001
Corpus ID: 37557213
Nuclear factor κB (NF-κB) transcriptionally activates genes that promote immunity and cell survival. Activation of NF-κB is…
Expand
Highly Cited
1999
Highly Cited
1999
Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control
Takeshi Suzuki
,
Y. Ohsugi
,
M. Uchida-Toita
,
T. Akiyama
,
Mitsuaki Yoshida
Oncogene
1999
Corpus ID: 19223677
HTLV-1 Tax oncoprotein interacts with various cellular factors and modulates transcription and the cell cycle. To identify more…
Expand
Highly Cited
1999
Highly Cited
1999
Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
A. Craig
,
L. Burch
,
B. Vojtěšek
,
J. Mikutowska
,
A. Thompson
,
T. Hupp
Biochemical Journal
1999
Corpus ID: 475264
The ability to separate the isoforms of human tumour suppressor protein p53 expressed in insect cells using heparin-Sepharose…
Expand
Highly Cited
1996
Highly Cited
1996
Characterisation of human cyclin G1 and G2: DNA damage inducible genes.
S. Bates
,
S. Rowan
,
K. Vousden
Oncogene
1996
Corpus ID: 34178865
Several genes have been identified as targets for transcriptional activation by the p53 tumour suppressor protein. Rodent cyclin…
Expand
Highly Cited
1993
Highly Cited
1993
A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
S. Madden
,
D. Cook
,
F. Rauscher
Oncogene
1993
Corpus ID: 2256915
The chromosome 11p13 Wilms' tumor locus (wt1) encodes a zinc finger-containing transcription factor (WT1). WT1 binds to the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE